Related Experiment Videos
Demyelinative brainstem encephalitis responsive to intravenous immunoglobulin therapy.
A Assa1, N Watemberg, Y Bujanover
1Pediatrics Department, Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel.
Pediatrics
|August 3, 1999
Summary
Intravenous immunoglobulin (IVIG) rapidly improved two children with acute demyelinating brainstem encephalitis. This suggests IVIG may be a first-line treatment for pediatric brainstem demyelinating lesions.
Area of Science:
- Neurology
- Immunology
Background:
- Acute demyelinating encephalitis is a rare neurological disorder.
- Brainstem involvement can lead to severe neurological deficits.
Observation:
- Two pediatric patients presented with acute demyelinating brainstem encephalitis.
- Both patients received intravenous immunoglobulin (IVIG) therapy.
Findings:
- Rapid clinical improvement was observed in both patients during IVIG treatment.
- These are the first reported cases of pediatric brainstem demyelinating lesions treated with IVIG.
Implications:
- IVIG may be an effective first-line treatment for acute demyelinating brainstem encephalitis in children.
- Further research is warranted to confirm the efficacy of IVIG in this condition.